In T1D and other pancreatic diseases, alterations at the level of these enzymes in beta cells have a major impact in proinsulin processing, proinsulin and insulin secretion (Sims et al., 2019), and overall beta cell function. This evidence concerns the gene INS and pancreas disorder.